Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

340B Guidance Withdrawn from OMB

February 3, 2017—The Office of Management and Budget (OMB) Jan. 30 withdrew the 340B Drug Pricing Program guidance from review.  The 340B guidance was one of three documents withdrawn as a result of the memorandum issued by the administration freezing the review of all regulations and guidance [see Washington Highlights, Jan. 27]. 

The 340B Program, administered by the Health Resources and Services Administration (HRSA), allows certain safety net hospitals to purchase outpatient drugs at a discount from drug manufacturers and use the savings to expand care services to vulnerable populations.  It is unclear if the guidance will be re-submitted for review at a later date. 

The AAMC provided comments on the proposed guidance during its comment period in 2015 [see Washington Highlights, Oct. 30, 2015].

Contact:

Mary Mullaney
Director, Hospital Payment Policies
Telephone: 202-909-2084
Email: mmullaney@aamc.org

.

 

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org